Back to Results

Teladoc Inc (TDOC)

Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum Small-Cap Stocks

Teladoc Health, Inc. is a common stock listing on the NYSE for a healthcare technology company focused on virtual care services. Through its Teladoc Health Integrated Care and BetterHelp segments, the company provides a range of remote medical and mental health services worldwide. Integrated Care includes general and specialist medical support, chronic condition management, mental health services, and telehealth technologies for hospitals and health systems. BetterHelp operates an online mental health platform that connects users with licensed clinicians through websites, mobile apps, phone, and text-based communication. Teladoc serves employers, health plans, hospitals, insurance companies, financial services firms, and individual members. Founded in 2002 and headquartered in New York, New York, the company operates under the Teladoc and BetterHelp brands.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-TDOC
$12.64
30.8% Upside
Undervalued
$7.71
-20.2% Downside
Overvalued
Great
—
—
—
0.0%
July 29, 2026
-10.2x
1.3x
0.7x
1.742 B
2.04 B
37.3%
99.3%
-15.0
—
-163.7%
Send a message
Valuation • Fair Value

Teladoc Inc (NYSE-TDOC) Fair Value by Valuation Model

Compare the primary fair value estimate for Teladoc Inc (NYSE-TDOC) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$12.64

Estimated upside of 30.8% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$13.45

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$11.47

Earnings power value estimate.

Comps Fair Value

$12.01

Comparable-company valuation reference.

Analyst Price Target

$7.71

Analysts imply downside of 20.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Teladoc Inc (NYSE-TDOC) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Teladoc Inc (NYSE-TDOC)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.514 B

Current operating scale indicator.

Revenue Forecast

2.506 B

Forward revenue estimate.

EBITDA

47.51 M

Current operating profitability reference.

EBITDA Forecast

279.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Teladoc Inc (NYSE-TDOC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Teladoc Inc (NYSE-TDOC)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.17

No elevated caution signal from this screen.

Altman Z-Score

-15.0

Lower score that deserves closer risk review.

FCF / Net Income

-163.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Teladoc Inc (NYSE-TDOC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Teladoc Inc (NYSE-TDOC)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 29, 2026

Days to Earnings

8

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Teladoc Inc (NYSE-TDOC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Teladoc Inc (NYSE-TDOC) Stock Forecast & Technical Outlook

Review Teladoc Inc (NYSE-TDOC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Teladoc Inc (NYSE-TDOC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Teladoc Inc (NYSE-TDOC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Teladoc Inc (NYSE-TDOC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Teladoc Inc (NYSE-TDOC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for Teladoc Inc (NYSE-TDOC) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Teladoc Inc (NYSE-TDOC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Teladoc Inc (NYSE-TDOC) has a Hold consensus, with 5 buy, 18 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 18
Sell 0
FAQ • Fast Investor Answers

Teladoc Inc (NYSE-TDOC) Stock FAQ

Quick answers about Teladoc Inc (NYSE-TDOC) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$12.64
Estimated upside 30.8%
Valuation Rating
Undervalued
Estimated upside of 30.8%
Analyst Target
$7.71
Implied downside 20.2%
Financial Health
Great
Current financial-health read

The current fair value estimate for Teladoc Inc (NYSE-TDOC) is $12.64. This implies an estimated upside of 30.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 30.8% versus the current market price.

The available analyst price target for Teladoc Inc (NYSE-TDOC) is $7.71. The analyst target implies estimated downside of 20.2%.

The current financial health read for Teladoc Inc (NYSE-TDOC) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Teladoc Inc (NYSE-TDOC) is July 29, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Teladoc Inc (NYSE-TDOC) is -10.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Teladoc Inc is 1.742 B.

The current enterprise value listed for Teladoc Inc is 2.04 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Teladoc Inc is NYSE-TDOC, and the stock is listed on NYSE.

Teladoc Inc (NYSE-TDOC) is listed on NYSE.

The current debt-to-total-capital ratio listed for Teladoc Inc is 37.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Teladoc Inc is 99.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NYSE View more

Veeva Systems Inc Class A (VEEV) Veeva Systems Inc Class A (VEEV)
Doximity Inc (DOCS) Doximity Inc (DOCS)
Evolent Health Inc (EVH) Evolent Health Inc (EVH)
Phreesia Inc (PHR) Phreesia Inc (PHR)
Claritev Corp (CTEV) Claritev Corp (CTEV)
American Well Corp (AMWL) American Well Corp (AMWL)